SCHEMBL8523430

SCHEMBL8523430

O=C1SC(Cc2ccccc2)C(=O)N1OCCn1cc(C(c2ccccc2)(c2ccccc2)c2ccccc2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 2/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2D6 P10635 1/20 0.33
PTPN7 P35236 1/20 0.32
THRB P10828 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 3/20 0.32
FFAR1 O14842 2/20 0.32
PPARG P37231 2/20 0.32
LMNA P02545 1/20 0.32
APEX1 P27695 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8524315 0.77 FFAR1 (0.53) MAPTKDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL8523431 0.75 POLB (0.37) MAPTTP53PTPN7THRBALDH1A1
SCHEMBL6032172 0.69 MAPT (0.53) MAPTKDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL8523852 0.67 ALDH1A1 (0.44) MAPTKDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL8523887 0.66 MAPT (0.43) MAPTKDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL7469293 0.66 MAPT (0.56) MAPTKDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL6090918 0.66 CREBBP (0.58) MAPTKDM4EALDH1A1APEX1
SCHEMBL27516237 0.65 MAPT (0.51) MAPTKDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL8687360 0.64 PPARG (0.48) MAPTKDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL8472101 0.64 MAPT (0.41) MAPTKDM4ECYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US claimed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed